KENNETH GORNEY: Open Payments
NPI 1255380796 · OKEMOS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$589 in 29 payments from 7 companies in 2025. Trend: 2023 $550 · 2024 $267 · 2025 $589
Food & beverage: $589
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 15 | $198 |
| Teva Pharmaceuticals USA, Inc. | 1 | $120 |
| Alkermes, Inc. | 4 | $90 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $78 |
| Vanda Pharmaceuticals Inc. | 2 | $55 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
Products named: ABILIFY MAINTENA, UZEDY, ARISTADA, CAPLYTA, FANAPT, REXULTI, Auvelity, INVEGA SUSTENNA.
Industry payments across MI — which companies pay providers there.
